These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8633828)

  • 61. Increase in trimethoprim-sulphamethoxazole (co-trimoxazole) resistance at Chris Hani Baragwanath Hospital, Soweto, in the AIDS era.
    Crewe-Brown HH; Reyneke MP; Khoosal M; Becker PJ; Karstaedt AS
    S Afr Med J; 2004 Jun; 94(6):440-2. PubMed ID: 15250455
    [No Abstract]   [Full Text] [Related]  

  • 62. Quality standard for the prophylaxis of Pneumocystis carinii pneumonia in adults and adolescents infected with human immunodeficiency virus.
    Phair JP; Masur H; Gross PA; Holmes KK; Kaplan JE
    Clin Infect Dis; 1995 Aug; 21 Suppl 1():S128-9. PubMed ID: 8547504
    [No Abstract]   [Full Text] [Related]  

  • 63. Should cotrimoxazole prophylaxis be taken by all adults with HIV in Africa?
    Mermin J; Lule JR; Ekwaru JP; Pitter C
    AIDS; 2005 May; 19(8):845-6. PubMed ID: 15867506
    [No Abstract]   [Full Text] [Related]  

  • 64. Treatment for cerebral toxoplasmosis protects against Pneumocystis carinii pneumonia in patients with AIDS. The Swiss HIV Cohort Study.
    Heald A; Flepp M; Chave JP; Malinverni R; Rüttimann S; Gabriel V; Renold C; Sugar A; Hirschel B
    Ann Intern Med; 1991 Nov; 115(10):760-3. PubMed ID: 1929023
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prevention of Pneumocystis carinii pneumonia.
    Med Lett Drugs Ther; 1988 Oct; 30(776):94-5. PubMed ID: 3050408
    [No Abstract]   [Full Text] [Related]  

  • 66. Prophylaxis of AIDS-related opportunistic infections (OIs).
    Hardy WD
    AIDS Clin Rev; 1989; ():125-50. PubMed ID: 2562216
    [No Abstract]   [Full Text] [Related]  

  • 67. Is toxoplasmosis prophylaxis necessary in cardiac transplantation? Long-term follow-up at two transplant centers.
    Baran DA; Alwarshetty MM; Alvi S; Arroyo LH; Lubitz S; Pinney S; Gass AL; Zucker MJ
    J Heart Lung Transplant; 2006 Nov; 25(11):1380-2. PubMed ID: 17097506
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Diagnostic accuracy of HIV-associated central nervous system toxoplasmosis.
    Marra CM; Krone MR; Koutsky LA; Holmes KK
    Int J STD AIDS; 1998 Dec; 9(12):761-4. PubMed ID: 9874125
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients.
    Green H; Paul M; Vidal L; Leibovici L
    Cochrane Database Syst Rev; 2007 Jul; (3):CD005590. PubMed ID: 17636808
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Relative potency of 10 drugs with anti-Pneumocystis carinii activity in an animal model.
    Hughes WT; Killmar JT; Oz HS
    J Infect Dis; 1994 Oct; 170(4):906-11. PubMed ID: 7930735
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Use of dapsone in the treatment of Pneumocystis carinii pneumonia in a foal.
    Clark-Price SC; Cox JH; Bartoe JT; Davis EG
    J Am Vet Med Assoc; 2004 Feb; 224(3):407-10, 371. PubMed ID: 14765801
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Therapeutic approaches for AIDS-related toxoplasmosis.
    Behbahani R; Moshfeghi M; Baxter JD
    Ann Pharmacother; 1995; 29(7-8):760-8. PubMed ID: 8520094
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Iron overload as a mechanism for the lowered survival in AIDS patients receiving dapsone-iron protoxalate for secondary prophylaxis of Pneumocystis carinii pneumonia.
    Weinberg GA
    J Infect Dis; 1996 Jul; 174(1):241-2. PubMed ID: 8656006
    [No Abstract]   [Full Text] [Related]  

  • 74. Cerebral toxoplasmosis and prophylaxis for Pneumocystis carinii pneumonia.
    Clotet B; Romeu J; Sirera G
    Ann Intern Med; 1992 Jul; 117(2):169. PubMed ID: 1605434
    [No Abstract]   [Full Text] [Related]  

  • 75. [Reply to the authors. Infectious complications in lung transplantation for cystic fibrosis].
    García-Morillo S; Respaldiza Salas N; Dapena Fernández FJ; de la Horra Padilla C
    Med Clin (Barc); 2006 Oct; 127(16):638. PubMed ID: 17183630
    [No Abstract]   [Full Text] [Related]  

  • 76. Methemoglobinemia in Transplant Recipient Patients: Future of Dapsone as
    Sahu KK; Lal A; Mishra AK; George SV
    Prog Transplant; 2020 Mar; 30(1):71-72. PubMed ID: 31894730
    [No Abstract]   [Full Text] [Related]  

  • 77. Antibiotic prophylaxis for the prevention of donor-acquired Toxoplasma gondii infection in transplant patients.
    Wreghitt TG; McNeil K; Roth C; Wallwork J; McKee T; Parameshwar J
    J Infect; 1995 Nov; 31(3):253-4. PubMed ID: 8586854
    [No Abstract]   [Full Text] [Related]  

  • 78. Quality standard for the prophylaxis of Pneumocystis carinii pneumonia in infants and children born to women infected with human immunodeficiency virus.
    Wilfert CM; Masur H; Gross PA; Kaplan JE; Holmes KK; Phair JP; Simonds RJ
    Clin Infect Dis; 1995 Aug; 21 Suppl 1():S132-3. PubMed ID: 8547506
    [No Abstract]   [Full Text] [Related]  

  • 79. Switch to atovaquone and subsequent re-challenge with trimethoprim-sulfamethoxazole for Pneumocystis prophylaxis in a kidney transplant population.
    McLaughlin MM; Galal A; Richardson CL; Sutton SH; Barr VO; Patel N; Mitchell P; Stosor V
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28833985
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Combining mortality and longitudinal measures in clinical trials.
    Finkelstein DM; Schoenfeld DA
    Stat Med; 1999 Jun; 18(11):1341-54. PubMed ID: 10399200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.